{"id":"W4394999927","doi":"10.1007/s13555-024-01147-7","title":"Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60","year":2024,"lang":"en","type":"article","venue":"Dermatology and Therapy","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"SKiN Health","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Quality of life (healthcare); Psoriasis; Scalp; Dermatology; Physical therapy; Psoriatic arthritis; Nursing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001410724,0.000193001,0.0006900217,0.00008291717,0.00005414331,0.000007726555,0.00005801923,0.0002571089,0.00001682409],"category_scores_gemma":[0.00003606645,0.0001432558,0.00005693498,0.0001257954,0.0006887666,0.0001081925,0.00004540985,0.0001334564,0.000001256485],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000005433596,"about_ca_system_score_gemma":0.00002779251,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004227735,"about_ca_topic_score_gemma":0.00005079075,"domain_scores_codex":[0.9983147,0.0003836745,0.0007022552,0.0003435322,0.00004349221,0.0002123527],"domain_scores_gemma":[0.9992068,0.0003025841,0.0002382846,0.0001670862,0.00005594954,0.00002933871],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001997429,0.0003703731,0.9497812,0.0000581948,0.0009618988,0.00001490516,0.0007741262,7.484621e-8,0.0006286322,0.0001494559,0.00008345371,0.04518019],"study_design_scores_gemma":[0.009097947,0.0004459212,0.9878451,0.00003886953,0.00006160502,0.000006007892,0.0002229101,0.000002893109,0.001590785,0.000175446,0.0003719331,0.0001406285],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904991,0.008660461,0.000007203694,0.00009283561,0.0001761516,0.0003818517,0.0001279401,0.00002521162,0.00002921457],"genre_scores_gemma":[0.9981806,0.001504946,0.00003078298,0.0001164644,0.000002283349,0.00002053247,0.0001054103,0.00001384032,0.00002518088],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04503956,"threshold_uncertainty_score":0.5841801,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02612450247803453,"score_gpt":0.2840526117640753,"score_spread":0.2579281092860407,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}